1.
Clarke S, Banfield K. S-Adenosylmethionine-dependent methyltransferases: potential targets in homocysteine-linked pathology. In: Carmel R, Jacobsen D, editors. Homocysteine in health and disease. Cambridge, UK: Cambridge University Press, 2001:63–78.Google Scholar
2.
Clarke S, Banfield K. Can elevated plasma homocysteine levels result in the inhibition of intracellular methyltransferases? In: Milstein S, Kapatos G, Levine RA, Shane B, editors. Chemistry and biology of pteridines and folates. Boston, MA: Kluwer Academic Publishers, 2002:557–62.Google Scholar
3.
Perna AF, Ingrosso D, Galletti P, Zappia V, De Santo NG. Membrane protein damage and methylation reactions in chronic renal failure. Kidney Int 1996; 5:358–66.CrossrefGoogle Scholar
4.
Hoffer LJ. Homocysteine remethylation and transsulfuration. Metabolism 2004; 53:1480–3.CrossrefGoogle Scholar
5.
Clarke S. A protein carboxyl methyltransferase that recognizes age-damaged peptides and proteins and participates in their repair. In: Cheng X, Blumenthal RM, editors. S-Adenosylmethionine-dependentmethyltransferases: structures and function. Singapore: World Scientific Publishing Company, 1999:123–40.Google Scholar
6.
Galletti P, Ingrosso D, Manna C, Clemente G, Zappia V. Protein damage and methylation-mediated repair in the erythrocyte. Biochem J 1995; 306:313–25.Google Scholar
7.
Clarke S. Aging as war between chemical and biochemical processes: protein methylation and the recognition of age-damaged proteins for repair. Ageing Res Rev 2003; 2:263–85.CrossrefGoogle Scholar
8.
Barber JR, Clarke S. Inhibition of protein carboxyl methylation by S-adenosyl-L-homocysteine in intact erythrocytes. Physiological consequences. J Biol Chem 1984; 259:7115–22.Google Scholar
9.
Perna AF, D'Aniello A, Lowenson JD, Clarke S, De Santo NG, Ingrosso D. D-Aspartate content of erythrocyte membrane proteins is decreased in uremia: implications for the repair of damaged proteins. J Am Soc Nephrol 1997; 8:95–104.Google Scholar
10.
Perna AF, Ingrosso D, De Santo NG, Galletti P, Zappia V. Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia. Kidney Int 1995; 47:247–53.CrossrefGoogle Scholar
11.
Perna AF, Ingrosso D, Zappia V, Galletti P, Capasso G, De Santo NG. Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine. J Clin Invest 1993; 91:2497–503.CrossrefGoogle Scholar
12.
Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49:31–62.CrossrefGoogle Scholar
13.
Ueland PM, Refsum H, Beresford SA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000; 72:324–32.Google Scholar
14.
Malinow MR, Bostom AG, Krauss RM, Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277:1775–81.Google Scholar
15.
Perna AF, Acanfora F, Satta E, Lombardi C, Ingrosso D, De Santo NG. Hyperhomocysteinemia and cardiovascular disease in uremia: the newest evidence in epidemiology and mechanisms of action. Semin Nephrol 2004; 24:426–30.CrossrefGoogle Scholar
16.
Jacobsen WJ. Cellular mechanisms of homocysteine pathogenesis in atherosclerosis. In: Carmel R, Jacobsen D, editors. Homocysteine in health and disease. Cambridge, UK: Cambridge University Press, 2001:425–40.Google Scholar
17.
Jakubowski H. Molecular basis of homocysteine toxicity in humans. Cell Mol Life Sci 2004; 61:470–87.CrossrefGoogle Scholar
18.
Jakubowski H. Homocysteine-thiolactone and S-nitrosohomocysteine mediate incorporation of homocysteine into protein in humans. Clin Chem Lab Med 2003; 41:1462–6.CrossrefGoogle Scholar
19.
Loehrer FM, Angst CP, Haefeli WE, Jordan PP, Ritz R, Fowler B. Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease. Arterioscler Thromb Vasc Biol 1996; 16:727–33.CrossrefGoogle Scholar
20.
Perna AF, Castaldo P, De Santo NG, Di Carlo E, Cimmino A, Galletti P, et al. Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism. Kidney Int 2001; 59:2299–308.CrossrefGoogle Scholar
21.
Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr 2001; 74:723–9.Google Scholar
22.
Wang H, Yoshizumi M, Lai K, Tsai JC, Perrella MA, Haber E, et al. Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem 1997; 272:25380–5.Google Scholar
23.
Perna AF, Ingrosso D, Satta E, Lombardi C, Galletti P, D'Aniello A, et al. Plasma protein aspartyl damage is increased in hemodialysis patients: studies on causes and consequences. J Am Soc Nephrol 2004; 15:2747–54.CrossrefGoogle Scholar
24.
Perna AF, Ingrosso D, De Santo NG, Galletti P, Brunone M, Zappia V. Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia. J Am Soc Nephrol 1997; 8:1899–905.Google Scholar
25.
Robinson K, Gupta A, Dennis V, Arheart K, Chaudhary D, Green R, et al. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 1996; 94:2743–8.CrossrefGoogle Scholar
26.
Ghandour H, Lin BF, Choi SW, Mason JB, Selhub J. Folate status and age affect the accumulation of L-isoaspartyl residues in rat liver proteins. J Nutr 2002; 132:1357–60.Google Scholar
27.
Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000; 275:29318–23.Google Scholar
28.
Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001; 10:433–43.CrossrefGoogle Scholar
29.
Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 2002; 99:5606–11.Google Scholar
30.
Outinen PA, Sood SK, Pfeifer SI, Pamidi S, Podor TJ, Li J, et al. Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood 1999; 9:4959–67.Google Scholar
31.
Kokame K, Kato H, Miyata T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes. J Biol Chem 1996; 271:29659–65.Google Scholar
32.
Zhou J, Werstuck GH, Lhoták S, de Koning ABL, Sood SK, Hossain GS, et al. Association of multiple cellular stress pathways with accelerated atherosclerosis in hyperhomocysteinemic apolipoprotein E-deficient mice. Circulation 2004; 110:207–13.Google Scholar
33.
Cai Y, Zhang C, Nawa T, Aso T, Tanaka M, Oshiro S, et al. Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH2-terminal kinase and promoter response element. Blood 2000; 96:2140–48.Google Scholar
34.
Zhang C, Kawauchi J, Adachi MT, Hashimoto Y, Oshiro S, Aso T, et al. Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochem Biophys Res Commun 2001; 289:718–24.Google Scholar
35.
Hashimoto Y, Zhang C, Kawauchi J, Imoto I, Adachi MT, Inazawa J, et al. An alternatively spliced isoform of transcriptional repressor ATF3 and its induction by stress stimuli. Nucleic Acids Res 2002; 30:2398–406.CrossrefGoogle Scholar
36.
Nonaka H, Tsujino T, Watari Y, Emoto N, Yokoyama M. Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine. Amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation 2001; 104:1165–70.Google Scholar
37.
Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Genet 2000; 1:11–9.Google Scholar
38.
Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 1:6–21.Google Scholar
39.
Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001; 293:1068–70.Google Scholar
40.
Endres M, Meisel A, Biniszkiewicz D, Namura S, Prass K, Ruscher K, et al. DNA methyltransferase contributes to delayed ischemic brain injury. J Neurosci 2000; 20:3175–81.Google Scholar
41.
Hansen RS, Stoger R, Wijmenga C, Stanek AM, Canfield TK, Luo P, et al. Escape from gene silencing in ICF syndrome: evidence for advanced replication time as a major determinant. Hum Mol Genet 2000; 9:2575–87.CrossrefGoogle Scholar
42.
Ingrosso D, Cimmino A, Perna AF, Masella L, De Santo NG, De Bonis M, et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003; 361:1693–9.Google Scholar
43.
Van Guldener C, Kulik W, Berger R, Dijkstra DA, Jakobs C, Reijngoud DJ, et al. Homocysteine and methionine metabolism in ESRD: a stable isotope study. Kidney Int 1999; 56:1064–71.CrossrefGoogle Scholar
44.
Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000; 275:29318–23.Google Scholar
45.
Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001; 10:433–43.CrossrefGoogle Scholar
46.
Choumenkovitch SF, Selhub J, Bagley PJ, Maeda N, Nadeau MR, Smith DE, et al. In the cystathionine beta-synthase knockout mouse, elevations in total plasma homocysteine increase tissue S-adenosylhomocysteine, but responses of S-adenosylmethionine and DNA methylation are tissue specific. J Nutr 2002; 132:2157–60.Google Scholar
47.
Loehrer FM, Angst CP, Brunner FP, Haefeli WE, Fowler B. Evidence for disturbed S-adenosylmethionine:S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions? Nephrol Dial Transplant 1998; 13:656–61.CrossrefGoogle Scholar
48.
Laukkanen MO, Mannermaa S, Hiltunen MO, Aittomaki S, Airenne K, Janne J, et al. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol. 1999; 19:2171–8.CrossrefGoogle Scholar
49.
Hiltunen MO, Turunen MP, Hakkinen TP, Rutanen J, Hedman M, Makinen K, et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 2002; 7:5–11.CrossrefGoogle Scholar
50.
Scarano MI, Strazzullo M, Matarazzo MR, D'Esposito M. DNA methylation 40years later: its role in human health and disease. J Cell Physiol 2005; 204:21–35.Google Scholar
51.
Bruniquel D, Schwartz RH. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 2003; 4:235–40.Google Scholar
52.
Yu Z, Kone BC. Hypermethylation of the inducible nitric-oxide synthase gene promoter inhibits its transcription. J Biol Chem 2004; 279:46954–61.Google Scholar
53.
Sutherland JE, Costa M. Epigenetics and the environment. Ann NY Acad Sci 2003; 983:151–60.Google Scholar
54.
Takai D, Gonzales FA, Tsai YC, Thayer MJ, Jones PA. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum Mol Genet 2001; 10:2619–26.CrossrefGoogle Scholar
55.
Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23:5293–300.CrossrefGoogle Scholar
56.
Ulrey CL, Liu L, Andrews LG, Tollefsbol TO. The impact of metabolism on DNA methylation. Hum Mol Genet 2005; 14:R139–47.CrossrefGoogle Scholar
57.
Devlin AM, Bottiglieri T, Domann FE, Lentz SR. Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemia. J Biol Chem 2005; 280:25506–11.Google Scholar
58.
Uji Y, Motomiya Y, Hanyu N, Ukaji F, Okabe H. Protein-bound homocystamide measured in human plasma by HPLC. Clin Chem 2002; 48:941–4.Google Scholar
59.
Perna AF, Satta E, Acanfora F, Lombardi C, Ingrosso D, De Santo NG. Increased plasma protein homocysteinylation in hemodialysis patients. Kidney Int. In press.Google Scholar
Comments (0)